Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd

Generic Health Pty Ltd filed an application against Otsuka Pharmaceutical Co Ltd in the Federal Court of Australia, seeking an interlocutory injunction against Otsuka. The dispute revolves around the issuance and scope of an injunction related to the manufacture and sale of generic medications. The Federal Court was tasked with determining whether the application for leave to appeal should be referred to a Full Court.

The court had to decide whether the application for leave to appeal should be referred to a Full Court, in accordance with the relevant procedural rules. This determination involved examining the significance and complexity of the legal issues presented in the appeal, as well as the potential impact of the appeal on the broader legal landscape. The court needed to assess whether the case warranted the attention of a Full Court or if it could be adequately resolved by a single judge.

In making its decision, the court considered the potential for the case to set a significant precedent and the importance of uniformity in the law. The court determined that the application should be heard and determined by a Full Court due to the complexity and significance of the legal issues involved. The court also ruled that the application for leave to appeal should be heard concurrently with, or immediately before, the appeal itself. Furthermore, the costs associated with the hearing on 5 April 2012, including the costs of the written submissions, were reserved for determination by the Full Court.